Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet in MEN1-associated primary hyperparathyroidism
2009-009502-79Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cinacalcet in primary hyperparathyroidism (PHPT) and Multiple endocrine neoplasia type 1 (MEN1), sponsored by Azienda Ospedaliero-Universitaria Careggi. Primary endpoints: Reduction or normalization of parathyroid hormone and calcium and Change in parathyroid tissue size. Started Jun 2009; status: active.
02
Drugs
cinacalcet
03
Conditions
primary hyperparathyroidism (PHPT)Multiple endocrine neoplasia type 1 (MEN1)
Beyond the preview
Go deeper on 2009-009502-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009502-79.